METHOD FOR EVALUATING TRANSPORTABILITY IN SEVERELY AFFECTED PATIENTS Russian patent published in 2006 - IPC A61B5/205 A61B10/00 

FIELD: medicine.

SUBSTANCE: one should determine ECG values, saturation (S), response of arterial pressure (AP) to inotropic support due to introducing dopamine (IS), microcirculation (M), central venous pressure (CVP), average arterial pressure (AvAP), hourly diuresis (D). In case of individual extrasystoles on ECG, C value being 91-90, IS being below 5 mcg kg/min, M being 2-3 sec, CVP being 4-6 cm watery column, AvAP 70 and more mm mercury column, D 30-40 ml/h each of these parameters should be evaluated as 0 points. In case of polytopic extrasystoles on ECG, at C value being 91-90 at FiO₂ being below 0.5, IS 5-10 mcg kg/min, M being equal to 3-5 sec, CVP of 1-4 cm watery column, AvAP 60 and more mm mercury column, D 20-30 ml/h each of these parameters should be evaluated as 1 point. At combination of polytopic extrasystoles and myocardial ischemia on ECG, C value being 91-90 at FiO₂ being above 0.5, IS above 10 mcg kg/min, M above 5 sec, CVP being below 0 or above 14 cm watery column, Av.AP 50 and more mm mercury column, D below 20 ml/h one should evaluate every value as 2 points. The values should be summarized and at total value ranged 0-6 severely affected patients should be considered as transportable people, at its value ranged 0-10 the preparation should be desired, at its value being 11 and more - it should be concluded upon nontransportability. The innovation enables to perform objective evaluation of severe state in affected patients.

EFFECT: higher accuracy of evaluation.

4 ex, 5 tbl